openPR Logo
Press release

Global Polycystic Ovary Syndrome Market Research and Forecast 2018-2023

06-29-2018 11:42 AM CET | Health & Medicine

Press release from: Orion Market Research

Global Polycystic Ovary Syndrome Market Research and Forecast

Polycystic ovary syndrome market is a hormonal disorder observed in females of reproductive ages. The disorder causes the excessive production of hormones in the female body, which include testosterone or androgens, hormones that are primarily associated with the male reproductive system. PCOS includes a range of symptoms such as irregular menstrual cycle, trouble in getting pregnant, cyst formation in the ovaries, excessive body and facial hair, and pelvic pain, among others. Moreover, the early diagnosis of the disorder is highly recommended by the physicians, as untreated PCOS may often lead to high cholesterol, type-2 diabetes, heart disease, insulin resistance, and high blood pressure.

Major factors contributing to the growth of the global polycystic ovary syndrome market include sedentary lifestyle and faulty dietary habits and increasing female obese population across the globe. Initiatives taken by the government and non-profit organizations to spread awareness regarding the early diagnosis of the disorder is significantly fueling the market growth. Moreover, increasing genetic and hormonal disorder in female population is a major cause for the increase of polycystic ovary syndrome patients across the globe. Lack of regulatory approved drugs for the treatment of PCOS and easy availability of generic and off-label drugs may restrain the growth of the global PCOS market. However, market players are focusing in the development of innovative and symptom specific drugs are expected to fuel the market growth in the near future.

Browse full report at: https://www.omrglobal.com/industry-reports/polycystic-ovary-syndrome-market/

The polycystic ovary syndrome market can be segmented on the basis of drug type, diagnosis type, treatment type, and distribution channel. Based on drug type, the market is segmented into diuretics, insulin sensitizing agents, antiandrogens, anti-depressants, ornithine decarboxylase inhibitors, anti-obesity, and oral contraceptive pills. Based on diagnosis type, the market is bifurcated into ultrasound, pelvic exam, and blood tests. Based on treatment type, the market is segmented into ovarian wedge resection, laparoscopic ovarian drilling, and acupuncture. Based on distribution channel, the market is diversified into hospital pharmacies, drug stores, retail pharmacies, fertility clinics, and e-commerce. Among type of drugs, the insulin-sensitizing agents segment holds a major share in the polycystic ovary syndrome market. This is owing to wide adoption of the drug for the treatment of insulin resistance, to prevent diabetes.

Related Reports: https://www.omrglobal.com/reports-category/healthcare/

The global polycystic ovary syndrome market is further analyzed on the basis of the geographical regions that are contributing significantly towards the growth of the market. North America holds a dominant position in the global polycystic ovary syndrome market, followed by Europe. This is mainly owing to sedentary lifestyle of the people leading to high prevalence of disorder in the region. High reimbursement policies by the government in the healthcare sector and awareness amongst the population regarding the early diagnosis of the disorder are significantly contributing towards the market growth in the region. Asia Pacific is projected to exhibit fastest growth in the global polycystic ovary syndrome market over the forecast period. This is due to large pool of female obese population in the region, especially in China.

Some of the key players operating in the global polycystic ovary syndrome market are Abbott Laboratories, Bayer AG, AstraZeneca, Novartis, Glaxosmithkline plc, Teva Pharmaceuticals, and Furocyst, among others. In order to sustain in the competitive market, these players adopt various strategies such as Acquisitions, mergers, expansions, joint ventures and product development and so on. For instance, in April, 2017, Astellas Pharma announced the acquisition of Ogeda SA, a Europe-based drugmaker. Through acquisition, Astellas will develop solutions for alleviating menopause without hormonal therapy. Moreover, the deal includes treatment trials of Phase II testing for polycystic ovary syndrome and uterine fibroids.

Some Brief Table of Contents of Report

CHAPTER 1. REPORT SUMMARY
1.1. RESEARCH METHODS AND TOOLS
1.2. MARKET BREAKDOWN
1.2.1. BY SEGMENTS
1.2.2. BY GEOGRAPHY
1.2.3. BY STAKEHOLDERS

CHAPTER 2. MARKET OVERVIEW AND INSIGHTS
2.1. DEFINITION
2.2. ANALYST INSIGHT & CURRENT MARKET TRENDS
2.3. REGULATIONS

CHAPTER 3. MARKET DETERMINANT
3.1. MOTIVATORS
3.2. RESTRAINTS
3.3. OPPORTUNITIES

CHAPTER 4. MARKET SEGMENTATION
4.1. GLOBAL POLYCYSTIC OVARY SYNDROME MARKET, BY DRUG TYPE
4.2. GLOBAL POLYCYSTIC OVARY SYNDROME MARKET, BY DIAGNOSIS TYPE
4.3. GLOBAL POLYCYSTIC OVARY SYNDROME MARKET, BY TREATMENT TYPE
4.4. GLOBAL POLYCYSTIC OVARY SYNDROME MARKET BY DISTRIBUTION CHANNEL

CHAPTER 5. COMPETITIVE LANDSCAPE
5.1. KEY COMPANY ANALYSIS
5.2. KEY STRATEGY ANALYSIS

TOC Continued…

For More Updates Follow LinkedIn: www.linkedin.com/company/omr-global-research/

About Orion Market Research

OMR is a market research company known for its qualitative and quantitative research reports. The company aims to provide business insights for decision making to our global clients. OMR provides syndicated and customized research reports, company profiling, consulting and other research-based services to global clients. At OMR, we believe in overcoming the competition by delivering quality reports on time.

CORPORATE OFFICE:

Orion Market Research Pvt Ltd
116, Shagun Arcade, Vijay Nagar Square
Indore – India- 452010
Email: info@omrglobal.com, support@omrglobal.com
India: +91-780-304-0404, +91-917-982-8694
Global: +1-646-755-7667

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Polycystic Ovary Syndrome Market Research and Forecast 2018-2023 here

News-ID: 1103704 • Views:

More Releases from Orion Market Research

Vegan Pet Food Market is Dazzling Worldwide and Forecast to 2031
Vegan Pet Food Market is Dazzling Worldwide and Forecast to 2031
The global vegan pet food market is anticipated to grow at a CAGR of 8.5% during the forecast period. In recent times, the invention of vegan alternatives in the pet food industry has been witnessed over the years. People are increasingly becoming bothered about the slaughter of animals and the environmental destruction caused by animal husbandry. This results in the changing preference toward vegan diets for both themselves and their pets, boosting
Vegan Protein Bars Market is Likely to Increase at a Significantly High CAGR during Forecast Period 2031 | BHU Foods, Clif Bar & Co., General Mills Inc.
Vegan Protein Bars Market is Likely to Increase at a Significantly High CAGR dur …
Vegan protein bars market is anticipated to grow at a CAGR of 11.2% during the forecast period. The consumer inclination toward plant-based food products owing to the increase in food allergies is one of the major factors driving the demand for vegan protein bars. As per the American College of Allergy, Asthma & Immunology, more than 50 million Americans have some kind of allergy. Food allergies are estimated to affect
Vegan Dessert Market Outlook 2024-2031: Trends and Opportunities/ Alternative Foods London Ltd. (OGGS), Bliss Unlimited, LLC (Cosmic Bliss), Danone S.A.
Vegan Dessert Market Outlook 2024-2031: Trends and Opportunities/ Alternative Fo …
The global vegan dessert market is anticipated to grow at a significant CAGR of 10.2% during the forecast period. The growing popularity and adoption of the vegan lifestyle in developed economies such as the US, Canada, and the UK, among others is the primary factor accelerating the market growth. In addition, this growing trend has increased the demand for dairy alternatives, which propels the consumption of oat-based, soy-based, and almond-based ingredients in
Vegan Chocolate Market is Size, Trends, Latest Insights, Analysis and Forecast 2024-2031/ Anhui Fuguang Life Technology Co. Ltd., BOROSIL, Hamilton Housewares Pvt. Ltd.
Vegan Chocolate Market is Size, Trends, Latest Insights, Analysis and Forecast 2 …
The global vegan chocolate market is anticipated to grow at a significant CAGR of 4.6% during the forecast period. Increasing demand for vegan products among the population, who are more concerned about their fitness and health is the major factor driving the growth of the vegan chocolate market across the globe. Vegan chocolates are high in proteins and contain low calories and fats which aids to lose weight. According to the World

All 5 Releases


More Releases for CHAPTER

SISA’s Dharshan Shanthamurthy Addresses ISACA Bangalore Chapter
Bengaluru May 1, 2019: SISA Information Security, a global payment security specialist, announced that Mr. Dharshan Shanthamurthy, Founder and CEO, SISA Information Security recently delivered an informative address on payment security to the ISACA Bangalore Chapter on Saturday 27th April 2019. Mr. Shanthamurthy drew from his own first hand observations of the payment industry, garnered over the years. He spoke about emerging trends in the payments industry, including some of
Chapter 4 of 'Meri Pyaari Bindu'
While the first three chapters of Ayushmann Khurrana and Parineeti Chopra starrer 'Meri Pyari Bindu' tickled our funny bones, the fourth chapter has already made its way. Parineeti shared it on her Twitter handle by tweeting, "So easy to scandalise Abhi's MOM!!! Hahhahahaha here is Chapter 4 :) Bindu v/s Ma 😎😎😎 #MeriPyaariBindu." The chapter 4 shows Tom and Jerry equation between Bindu and Abhimanyu's mom. Bindu, who is Abhi's neighbour
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Robert Wolf as the new Chapter President of AFEA’s Orange, CA Chapter. With the addition of Robert Wolf as the new Chapter President, AFEA is expanding
AFEA Welcomes New Chapter President
The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Anthony Cucchi as the new Chapter President of AFEA’s Newton Square, PA Chapter. With the addition of Anthony Cucchi as the new Chapter President, AFEA is expanding its geographical footprint to cover
AFEA Welcomes New Chapter President
Leader in Financial Literacy Continues to Expand The American Financial Education Alliance is dedicated to providing financial education and increasing financial literacy within communities all over the country. Today, the Board of Directors has chosen to continue to do just that, by unanimously voting in Angelica Jones as the new Chapter President of AFEA’s Glendale, California Chapter. With the addition of Angelica Jones as the new Chapter President, AFEA is expanding
SPS/GZ to Present at the Chapter Meeting of the Chicago Chapter of the NASPP
Chicago, IL, October 20, 2010 -- Stock Plan Solutions/Green Zapato LLC (SPS/GZ), a leader in equity compensation administration and outsourcing today announced that Rick Zatz, CEP, will be presenting at the meeting of the Chicago Chapter of the NASPP in October 27, 2010. The U.S. Treasury Department issued the final regulations relating to the return information statement requirements under IRC 6039. These regulations impose return and information statement reporting requirements on